do not combine dpp-4 inhibitors with glp-1 receptor agonists guideline It's the first in a class of drugs called do not combine dpp-4 inhibitors

Offensive language, hate speech, personal attacks, and/or defamatory statements are not permitted

As type 2 diabetes becomes a more common condition among women of reproductive age, and with the recent approval of GLP-1 receptor agonists such as semaglutide to treat obesity, the number of exposed pregnancies is likely to increase

Reasons for Discontinuation Of GLP1 Receptor Agonists: Data From a Real-World Cross-Sectional Survey of Physicians and Their Patients With Type 2 Diabetes

Interestingly, concurrent same-day colonoscopy was identified as a protective factor, with a lower risk of food retention (OR 0.18, p -value = 0.003) in patients undergoing both EGD and colonoscopy [29]

Groups given -MSTN/-ActA were dosed weekly at 50 mg/kg starting Week 2 of the study until Week 12

These could be especially helpful during the menopausal transition, when the diagnosis of these conditions increases